Metropolis Healthcare Limited (BOM:542650)
556.65
+16.00 (2.96%)
At close: Aug 21, 2026
Metropolis Healthcare Revenue
Metropolis Healthcare had revenue of 4.50B INR in the quarter ending June 30, 2026, with 16.62% growth. This brings the company's revenue in the last twelve months to 17.10B, up 21.80% year-over-year. In the fiscal year ending March 31, 2026, Metropolis Healthcare had annual revenue of 16.46B with 23.64% growth.
Revenue (ttm)
17.10B
Revenue Growth
+21.80%
P/S Ratio
6.75
Revenue / Employee
3.81M
Employees
4,484
Market Cap
115.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 16.46B | 3.15B | 23.64% |
| Mar 31, 2025 | 13.31B | 1.23B | 10.23% |
| Mar 31, 2024 | 12.08B | 594.99M | 5.18% |
| Mar 31, 2023 | 11.48B | -801.26M | -6.52% |
| Mar 31, 2022 | 12.28B | 2.30B | 23.08% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 841.37M |
| Pramodini Medicare | 622.88M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 259.03M |
Metropolis Healthcare News
- 17 days ago - Metropolis Healthcare Transcript: Q1 26/27 - Transcripts
- 17 days ago - Metropolis Healthcare Quarterly report: Q1 2027 - Filings
- 17 days ago - Metropolis Healthcare Slides: Q1 2027 - Filings
- 18 days ago - Earnings To Watch: Metropolis Healthcare Ltd (BOM:542650) Q1 2027 -- GF Value Sees 16% Upside - GuruFocus
- 3 months ago - Metropolis Healthcare concall update: Management targets 13-15% growth in FY27 despite Q4 miss - Business Upturn
- 3 months ago - Metropolis Healthcare Transcript: Q4 25/26 - Transcripts
- 3 months ago - Metropolis Healthcare Quarterly report: Q4 2026 - Filings
- 3 months ago - Metropolis Healthcare Slides: Q4 2026 - Filings